Drug Profile
Robalzotan
Alternative Names: AZD 7371; NAD 299Latest Information Update: 18 Nov 2008
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antidepressants; Anxiolytics; Benzopyrans; Gastrokinetics; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Gastrointestinal disorders; Irritable bowel syndrome; Major depressive disorder; Overactive bladder
Most Recent Events
- 19 Aug 2002 Discontinued - Phase-II for Anxiety disorders in Sweden (unspecified route)
- 19 Aug 2002 Discontinued - Phase-II for Depression in Sweden (unspecified route)
- 04 May 2000 Phase-II clinical trials for Anxiety disorders in Sweden (Unknown route)